SPOTLIGHT: Bayer: Nexavar boosts blood pressure


Bayer and Onyx Pharmaceuticals defended Nexavar against a new Lancet article that concludes the cancer drug causes high blood pressure; the companies say that risk is already highlighted on the product's label. Report | Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.